| Unique ID issued by UMIN | UMIN000056625 |
|---|---|
| Receipt number | R000064718 |
| Scientific Title | Three-sided mattress pancreaticojejunostomy in pancreatoduodenectomy: A Single-arm Pilot Study |
| Date of disclosure of the study information | 2025/01/04 |
| Last modified on | 2025/07/06 09:05:12 |
Three-sided mattress pancreaticojejunostomy in pancreatoduodenectomy: A Single-arm Pilot Study
Three-sided mattress pancreaticojejunostomy in pancreatoduodenectomy: A Single-arm Pilot Study
Three-sided mattress pancreaticojejunostomy in pancreatoduodenectomy: A Single-arm Pilot Study
Three-sided mattress pancreaticojejunostomy in pancreatoduodenectomy: A Single-arm Pilot Study
| Japan |
Diseases in the pancreatic head region
| Hepato-biliary-pancreatic surgery |
Malignancy
NO
To evaluate the safety and usefulness of a "three-sided mattress suture method" in which mattress sutures are added to the superior and inferior sides of the pancreaticojejunostomy site after the modified Blumgart method in pancreaticojejunostomy following pancreaticoduodenectomy.
Safety,Efficacy
Confirmatory
the rate of postoperative pancreatic fistula (ISGPF; GradeB or C)
Observational
| 18 | years-old | <= |
| Not applicable |
Male and Female
1) Patients judged to have soft pancreas among those scheduled for pancreaticoduodenectomy.
2) The diameter of the main pancreatic duct at the planned pancreatic resection site is 5 mm or less on preoperative CT images.
3) ECOG-PS is 0-1.
4) Age 18 years or older.
5) The functions of major organs (bone marrow, heart, liver, kidneys, lungs, etc.) are maintained.
6) Sufficient judgment to understand the content of the research and providing written informed consent.
1) Serious ischemic heart disease.
2) Complication of liver cirrhosis or active hepatitis.
3) Dyspnea requiring oxygen administration due to interstitial pneumonia or pulmonary fibrosis.
4) Undergoing dialysis for chronic renal failure.
5) Requiring combined resection of surrounding organs.
6) Considered to require arterial reconstruction of the superior mesenteric artery, common hepatic artery, celiac artery, etc.
7) Active double cancers that may affect adverse events or overall survival.
8) Long-term oral steroid use that may cause adverse events.
9) Psychosis or psychiatric symptoms judged to potentially cause difficulty in participation in the study.
10) Any other person who the principal investigator or researcher deems inappropriate.
20
| 1st name | Ken-ichi |
| Middle name | |
| Last name | Okada |
Tokai University
Department of Gastrointestinal Surgery
259-1193
143 Shimokasuya, Isehara-shi, Kanagawa-ken
0463931121
kokada@tokai.ac.jp
| 1st name | Shigenori |
| Middle name | |
| Last name | Ei |
Tokai University
Department of Gastrointestinal Surgery
2591193
143 Shimokasuya, Isehara-shi, Kanagawa-ken
0463931121
ei.shigenori.h@tokai.ac.jp
Tokai University
Self funding
Self funding
Research Ethics Committee, Tokai University School of Medicine
143 Shimokasuya, Isehara-shi, Kanagawa-ken
0463931121
tokai-rec@tokai.ac.jp
NO
| 2025 | Year | 01 | Month | 04 | Day |
Unpublished
Open public recruiting
| 2021 | Year | 07 | Month | 01 | Day |
| 2021 | Year | 08 | Month | 10 | Day |
| 2024 | Year | 04 | Month | 01 | Day |
| 2025 | Year | 04 | Month | 01 | Day |
not particular
| 2025 | Year | 01 | Month | 04 | Day |
| 2025 | Year | 07 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064718